Table 2 gives recommended starting doses of Renagel based on a patient's current calcium acetate dose. Doses in excess of 5 mg daily have not been studied in pediatric patients. In clinical studies, the majority of patients required 10 mg [see Clinical Studies (14.4)].The effective antihypertensive oral dose in pediatric patients ages 6 to 17 years is 2.5 mg to 5 mg once daily. Feb 21, 2011. Subsequently, the physician may continue decreasing the dose but at a more gradual rate.The usual initial antihypertensive oral dose of amlodipine besylate tablets, USP is 5 mg once daily with a maximum dose of 10 mg once daily.Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding amlodipine besylate tablets, USP to other antihypertensive therapy.Adjust dosage according to each patient's need. In clinical studies, the majority of patients required 10 mg [see CLINICAL STUDIES (14.4)].

Le bésylate d'amlodipine est un antagoniste des canaux calciques de type L (responsables de la contraction des muscles lisses) à longue action, utilisé comme antihypertenseur et pour le traitement de l'angine de poitrine (voir Inhibiteur calcique).

Increases may be made if indicated. In clinical studies, the majority of patients required 10 mg [see Clinical Studies (14.4)].The effective antihypertensive oral dose in pediatric patients ages 6 to 17 years is 2.5 mg to 5 mg once daily. In general, wait 7 to 14 days between titration steps. Doses of 3600 mg/day have also been administered to a small number of patients for a relatively short duration, and have been well tolerated.

Doses in excess of 5 mg daily have not been studied in pediatric patients . Doses in excess of 5 mg daily have not been studied in pediatric patients [see Clinical Pharmacology (12.4), Clinical Studies (14.1)].The dose of clonidine hydrochloride tablets, USP must be adjusted according to the patient’s individual blood pressure response. See ADVERSE REACTIONS section for information related to dosage and side effects.The effective antihypertensive oral dose in pediatric patients ages 6 to 17 years is 2.5 mg to 5 mg once daily. In clinical studies, the majority of patients required 10 mg [see Clinical Studies (14.4)].The effective antihypertensive oral dose in pediatric patients ages 6 to 17 years is 2.5 mg to 5 mg once daily. The recommended and initial dosage is 20 mg/day. Most patients will require 10 mg for adequate effect [see Adverse Reactions (6)].The recommended dose range for patients with coronary artery disease is 5 to10 mg once daily. Titration may proceed more rapidly, however, if clinically warranted, provided the patient is assessed frequently.The recommended dose for chronic stable or vasospastic angina is 5–10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency. (2.1)●  Pediatric starting dose: 2.5 mg to 5 mg once daily. Duration of Treatment – Re-treatment with Interferon alfa-2b/RIBASPHERE in Relapse PatientsIn patients who relapse following nonpegylated interferon monotherapy, the recommended duration of treatment is 24 weeks.The recommended dose of RIBASPHERE is 15 mg/kg per day orally (divided dose AM and PM). In general, wait 7 to 14 days between titration steps. Dosages up to 2400 mg/day have been well tolerated in long-term clinical studies. Coronary artery disease: The recommended dose range for patients with coronary artery disease is 5–10 mg once daily. (See CLINICAL PHARMACOLOGY).Amlodipine has been safely administered with thiazides, ACE inhibitors, beta-blockers, long-acting nitrates, and/or sublingual nitroglycerin.The usual initial antihypertensive oral dose of amlodipine besylate tablets is 5 mg once daily with a maximum dose of 10 mg once daily. Refer to adult dosing table for greater than 61 kg body weight.The recommended duration of treatment is 48 weeks for pediatric patients with genotype 1. Titration may proceed more rapidly, however, if clinically warranted, provided the patient is assessed frequently.The recommended dose for chronic stable or vasospastic angina is 5–10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency.